Palatin Technologies, Inc.
0KF3.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.3M
Close$
Share Statistics
| Market cap | $15.30 Million |
|---|---|
| Enterprise Value | $8.03 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.96 |
| Beta | -0.1 |
| Outstanding Shares | 3,921,182 |
Return
| Return on Equity | -125.30% |
|---|---|
| Return on Assets | -98.29% |
| Return on Invested Capital | -128.57% |
Valuation & Multiples
| P/E Ratio | -1.64 |
|---|---|
| PEG | -1.72 |
| Price to Sales | 2.9 |
| Price to Book Ratio | 8.71 |
| Enterprise Value to Revenue | 0.61 |
| Enterprise Value to EBIT | -0.93 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 28, 2026
EPS Estimate
$-1.20
Average shareholder expectationRevenue Estimate
$1.50 M
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
$2.51 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Palatin Technologies Inc.
25 employees
CEO: Carl Spana Palatin Technologies, Inc., established in Cranbury, New Jersey, in 1986, is a biopharmaceutical company focused on developing specialized, receptor-targeting therapeutics for various medical conditions within the United States. The firm...